Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Community still unaware what a podiatrist offers, as Healthia continues expansion

  • In News
  • July 4, 2019
  • Alfred Chan
Community still unaware what a podiatrist offers, as Healthia continues expansion

National healthcare operator Healthia (ASX: HLA) has continued its acquisition of podiatry clinics in what market research identified as a “largely untapped market”.

In a study conducted by the company with a group of 500 Australians, less than 50% were able to accurately define what a podiatrist is, whilst less than 15% of participants had actually visited a podiatrist in the last 12 months.

“It’s a common perception for people to think we just clip toenails and provide routine foot care for the elderly, but a podiatrist actually provides a range of medical assessments, procedures and services from the knee down from toddler years onwards,” said My FootDr Podiatrist and CEO Darren Stewart

“You only get one pair of feet to keep you upright and mobile your whole life, and historically people have not given their feet a second thought until they are at crisis point and in a lot of pain.

“One area of podiatry advancing the most is the prescription and fitting of custom-made foot orthotics, paired with lifestyle appropriate footwear.

“This treatment can provide healthcare benefits to all areas of the body by improving the alignment of the feet and reducing areas of pressure that can result in injury to the tendons, joints and skin.

“The market research we conducted reaffirmed our mission to enrich people’s lives through world class healthcare which is one of the reasons we are seeing increasing demand for services across our podiatry clinic network.”

Since listing on the ASX in September 2018, Healthia has continued its expansion of allied healthcare businesses, nationally.

This includes their latest round of acquisitions comprising of 6 podiatry clinics and 3 physiotherapy clinics which are expected to deliver the company a further $1.34m of annualised earnings.

Largely acquiring these clinics using a $37 million facility agreement with ANZ and Bank of Queensland, the rising awareness around foot health care and podiatry services presents an opportune time for Healthia which has continued their national expansion

Upon settlement of their most recent round of acquisitions, the company’s portfolio will comprise of 81 podiatry clinics, 36 physiotherapy clinics and 9 hand therapy clinics, as well as iOrthotics, – Australia’s largest producer of foot orthotics.

 

*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  •  
  •  
  •  
  •  
  • healthcare
  • healthia
  • HLA
  • physio
  • physiotherapy
  • podiatry
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • jitesh
    July 29, 2019, 8:26 am

    Helpful

    Reply
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.